MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025

Rhea-AI Summary

MaxCyte (NASDAQ: MXCT) will report third quarter 2025 financial results after the U.S. market close on Wednesday, November 5, 2025.

Company management will host an earnings conference call at 4:30 p.m. Eastern Time the same day. Investors must register online in advance to join the call, and a live and archived webcast will be available in the Events section of MaxCyte's investor website at https://investors.maxcyte.com/.

ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the third quarter 2025 after the U.S. market close on Wednesday, November 5^th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.

Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.

About MaxCyte
At MaxCyte^®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation^® technology and SeQure DX™ gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we've been advancing cell engineering, shaping the future of medicine. Learn more at maxcyte.com and follow us on X and LinkedIn.

Investor Relations
Gilmartin Group
David Deuchler, CFA
+1 415-937-5400
ir@maxcyte.com

Media Relations
Oak Street Communications
Kristen White
+1 415-608-6060
kristen@oakstreetcommunications.com

FAQ

When will MaxCyte (MXCT) report Q3 2025 results?

MaxCyte will release Q3 2025 results after the U.S. market close on November 5, 2025.

What time is the MaxCyte (MXCT) Q3 2025 earnings call?

The management conference call is scheduled for 4:30 p.m. Eastern Time on November 5, 2025.

How can investors join the MaxCyte (MXCT) Q3 2025 earnings call?

Investors must register online in advance to access the conference call; registration is recommended at least one day before the event.

Where can I find the live webcast for MaxCyte (MXCT) Q3 2025 results?

A live and archived webcast will be available on the Events section of MaxCyte's investor website: https://investors.maxcyte.com/.

Will the MaxCyte (MXCT) Q3 2025 webcast be available after the call?

Yes, an archived webcast will be posted on the company's investor site after the live event.

Do I need to register to access the archived MaxCyte (MXCT) earnings webcast?

The release says live and archived webcasts will be available on the investor site; registration is required for the live call, and the archived webcast is accessible via the Events page.